Latest Oncology news and updates from Switzerland. AI-curated articles covering Oncology topics.
Swiss pharmaceutical giant Novartis has announced the acquisition of British start-up Myricx Bio for an initial $1.1 billion, a strategic move to bolster its portfolio of antibody-drug conjugates for treating various solid tumours.
From trusted Swiss news outlets